CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 3.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,723 | +22.4% | 467 | 0.0% | 0.00% | – |
| Q2 2023 | $10,391 | +2.7% | 467 | 0.0% | 0.00% | – |
| Q1 2023 | $10,115 | +55.6% | 467 | +45.9% | 0.00% | – |
| Q4 2022 | $6,499 | -27.8% | 320 | -13.0% | 0.00% | – |
| Q3 2022 | $9,000 | +28.6% | 368 | +29.1% | 0.00% | – |
| Q2 2022 | $7,000 | 0.0% | 285 | -14.4% | 0.00% | – |
| Q1 2022 | $7,000 | +133.3% | 333 | +158.1% | 0.00% | – |
| Q4 2021 | $3,000 | +50.0% | 129 | +27.7% | 0.00% | – |
| Q3 2021 | $2,000 | -66.7% | 101 | -60.1% | 0.00% | – |
| Q1 2021 | $6,000 | -98.2% | 253 | -99.0% | 0.00% | -100.0% |
| Q4 2018 | $332,000 | -42.9% | 24,832 | -40.1% | 0.00% | -50.0% |
| Q3 2018 | $581,000 | +16.4% | 41,452 | +30.6% | 0.00% | +33.3% |
| Q2 2018 | $499,000 | -8.6% | 31,751 | -4.4% | 0.00% | -25.0% |
| Q1 2018 | $546,000 | – | 33,211 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,370,017 | $181,295 | 9.31% |
| Novo Holdings A/S | 3,377,768 | $73,162,455 | 4.83% |
| Parallel Advisors, LLC | 3,724,573 | $80,674,251 | 2.72% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $770 | 2.24% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| S&T BANK/PA | 350,924 | $7,601 | 1.37% |
| Birchview Capital, LP | 50,000 | $1,083 | 0.85% |
| Clearview Wealth Advisors LLC | 34,275 | $742,397 | 0.75% |
| Granite Investment Partners, LLC | 795,076 | $17,221,346 | 0.72% |